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Dubos' (1) finding of a naturally occurring antibiotic, now known as tyro-
thricin, may prove to be an event as important to topical medication as the dis-
covery of penicillin has been to systemic therapy. Only recently have we begun
to appreciate its significance. Like penicillin, tyrothricin is selective in its ac-
tion. Most organisms susceptible to tyrothricin's antibiotic affect are Gram-
positive. Streptococcus hemolyticus (Groups A, B, C, and D), Staphylococcus
aureus, Neisseria gonorrheae, Diplococcus pneumoniae, Lactobacillus plantarum,
Corynebacterium diphtheriae, Myeobacteriuin tuberculosis, Bacillus ant hracis,
Clostridium tetani and Neisseria meningitidis have been reported most vulner-
able. Table 1 summarizes these data, with special reference to gramicidin.
The limiting factors in the usefulness of tyrothricin, and its active components,
particularly gramicidin, are its hemolytic properties and low water solubility.
Recently, commercial preparations of tyrothricin, soluble in water, have been
prepared. An attempt has been made to attenuate the systemic toxicity, which
is at least partly due to its hemolytic action. Lewis (2) et al., at the Western
Regional Research Laboratories, U. S. Department of Agriculture, Albany, Cali-
fornia, have modified gramicidin chemically. One of these modifications, a form-
alçiehyde derivative, showed reduced hemolytic properties, some loss in total
systemic toxicity for laboratory animals and yet retention of at least 50% of its
antibiotic activity. Against one organism, Staphylococcus aureus, antibiotic
activity actually was increased in vitro. In addition, the formaldehyde deriva-
tive was more soluble (0.1%) in aqueous alcohol (50%).
These preliminary observations prompted Fraenkel-Conrat, et a!., in the same
group of workers at Albany, California, to prepare and study other modifications
of gramicidin. As a result, a succinyl-derivative and a succinyl-methylal
derivative of gramicidin were produced. The first was soluble in 10% ethyl
alcohol (or propylene glycol) and after neutralization with sodium hydroxide,
further dilutions in water could be made without precipitation. It was less
hemolytic and only slightly less effective against Staphylococcus aureus, according
to these workers (3). The succinyl-methylal derivative as a sodium salt could
be dissolved in water. Its antibacterial activity was about one-fifth that of
gramicidin, and it was only slightly hemolytic.
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We became interested in a comparison of these agents because, like subtilin, an
antibiotic derived from Bacillus subtilis by Jansen and Hirschmann in 1944 (4),
they have the common property of lowering surface tension. Subtilin differs
from gramicidin, however, in being non-hemolytic. Graph I indicates the degree
of surface action noted, as compared with other antibiotics such as penicillin and
TABLE 1
Partial List of Organisms Inhibited by Gramicidin*
ORGANISM
CONCENTRATION OP GRAMICIDIN
REQUIRED TO INHIBIT GROWTH
(T/cc. OPBROTH CONTAINING
1 % SERUM ALBUMIN)
Diplococcus pneumoniae
Streptococcus hemolyticus (groups A, B, C)





Corynebacteriuni diphtheriae and diphtheroid bacilli
Mycobacterium tuberculosis
Bacillus ant/iracis
Saprophytic aerobic sporulating bacilli


















* From J. Henderson, J. Amer. Pharm. Assn., 35: 142, 1946.
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Growth at 37°C. for 24 hours.
streptomycin. An evaluation of the various gramicidins against Lactobacillus
plantarum, simply as an assay procedure, yielded the results shown in table 2.
Various micro-organisms which produce superficial lesions in man should be
studied in a similar manner.
While there has been little advance as yet in a practical direction toward
chemical modification of antibiotics of this class, this would appear to be one of
NEW SIJRFACE ACTJVE ANTIBIOTICS 27
the most fruitful fields for future endeavor. Actually, until we know the chemi-
cal structure and precise physical-chemical characteristics of useful agents, we
shall have to work largely with unknowns. Proper identification of antibiotics
now available would be most helpful in studies of this sort.
Some studies have been partially successful with the use of "wetting agents"
such as "Tergitol" and "Tween 80" (polyoxyalkylene sorbitan oleate). The
latter, in a concentration of 500 ,g/ml. exhibits no activity against staphylococci.
The effect of this non-ionized surface active agent was compared with an anionic
surface active agent, lauryl sulfate ("Duponol C"), which killed staphylococci at
a concentration of 830 g/ml. Tyrocidin, (one of the components of tyrothricin),
a basic lipid-soluble polypeptide used as an example of a naturally occurring
cationic surface active agent, killed staphylococci at the lowest concentration,
165 ,ug/ml. (5).
TABLE 3
Efftct of "wettina agents" on the in vitro activity of subtilin against Lactobacillus plantarurn




1:20,000 — — — + —
1:640,000 — — — +++ +
1:1,280,000 — —
1:2,560,000 +
1:5,120,000 ++ + ++ ++++ +++
Control ++++ ++++ ++++ ++++ ++++
* Tween 80 is the trade marked name for an oleic ester of sorbitan conjugated with
ethylene oxide.
f Tergitol is sodium sulfate derivative of 3,9-diethyl tridecanol-6.
Our interest centered about the possibility of producing a synergic effect be-
tween an active antibiotic, such as subtilin, and a suitable wetting agent such as
"Tween 80." Conceivably a wetting agent might accomplish two purposes, one
—to disperse the organisms which might tend to clump and not be available for
the action of a "contact" antibiotic; and two—to disperse the antibiotic uni-
formly throughout the area where the organisms are found. Lactobacillus
plantaruni was used as the first test organism. The results accomplished by
combining a wetting agent or an anionic surface active agent are shown in table 3.
It will be noted that the anionic agent, sodium lauryl sulfate, actually inter-
fered with the antibiotic activity of subtilin. However, both "Tergitol" and
"Tween 80" enhanced its antibiotic activity. The latter increased the level of
in vitro antibacterial effect from a range of between 1:160,000 to 1:320,000 to a
1:1,280,000 dilution—a significant difference. "Tween 80" alone exhibited no
bacteriostatic or bacteriocidal activity against the lactobacillus in the concentra-
tions employed. Actually, multiplication of the organism occurred in 5% solu-
tion of "Tween 80" in broth. On the other hand, "Tergitol" in 0.05% concen-
tration was definitely bacteriostatic when used alone.
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Turning to a pathogen for man, Mycobacterium tuberculosis (6), a medium was
used which is a modification of one recently proposed by Dubos (7).
This permits perceptible growth of tubercle bacilli within seventy-two hours.
"Tween 80" was included in the medium, 0.5% of a 10% aqueous solution. A
rapid growing phase of the mycobacteria was used. A uniform inoculum of
computable quantity (e.g. Hopkins tube method) could be employed, thus
placing the assay on a more quantitative basis.
Under the conditions of this test an active lot of subtilin (U. C. Lot 8) ex-
hibited an antibacterial effect in three days at a level of 1: 400,000 dilution. This
was maintained over a twelve day period of observation. Table 4 indicates the
results of these tests. Dubos' modified medium is more satisfactory for this
purpose than Long's synthetic medium which requires three weeks for growth of
mycobacteria.
TABLE 4












— = No growth.
* Medium contains 0.5% of 10% "Tween 80."
Kelso and Thompson (8) have made an effort in another direction to enhance
the activity of tyrothricin. They employed a mixture containing 1:2,000 parts
of tyrothricin together with 1:50 parts of sulfadiazine. In vitro such a mixture
exhibited activity against a number of microorganisms commonly found in the
upper respiratory tract. It was reported that the mixture was more active
than either agent when used alone.
Something should be said about the possible mechanism of anti-bacterial action
of naturally occurring surface depressant antibiotics. Since the gramicidins are
hemolytic, it would appear likely that an analogous process occurs with bacteria
susceptible to their action. Bacteriolysis or actually an autolysis of an easily
observed organism, such as a trypanosome, has been observed by one of us (H.
H. A.) when subtilin is present in suitable concentration (9). Rupture of the
cell membrane of Endanieba histolytica has also been observed when cultured
trophozoites are exposed to subtilin. Plate I demonstrates this phenomenon.
It would appear not unlikely that similar processes of destruction also occur in
bacteria that come into actual contact with surface depressing substances. In
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fact, Hotchkiss has reported (5) that cytolytic injury does occur when surface
active agents act upon staphylococci and similar observations have been made
with streptococci and Escherichia coli. It should be noted that this effect has
PLATE I
Effect of an antibiotic (Subtilin) on the cell membrane of
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GRAPH I. EFFECT OF ANTIBIOTICS ON SURFACE TENSION
not been observed with the usual synthetic so-called "antiseptics". Such injury
would appear sufficient to explain loss of metabolic activity and death of the
bacterial cell caused by a surface agent.
The recent reports of Ramon, Richou and Ramon (10) deserve comment.
-'.4S
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This group of workers have studied microbial antagonism in general, with partic-
ular reference to the antagonistic properties of culture filtrates of Bacillus sub-
tilis. In their preliminary experimental studies heated filtrates retained their
activity against the anthrax bacillus and the toxins of diphtheria, tetanus and
botulin. It was shown that the necrotic power of staphylococcus toxin could be
destroyed by filtrates of Bacillus subtilis but not by penicillin. Gale and Taylor
(11) have reported that the presence of tyrocidin (0.3—1.0 mgm) in the suspension
liquor liberated amino acids (lysine and glutamic acid) from the internal environ-
ment of Streptococcus faecalis. "Aerosol OT" (cetyl trimethyl ammonium bro-
mide) behaved similarly while gramicidin, penicillin and other agents did not.
Henderson (12) has emphasized that gramicidin differs from other "an-
tiseptics" commonly employed for topical action because it is not inactivated by
serum proteins. Subtilin, likewise is not inactivated by albumin (5%) or glob-
ulin (1%). Table 5 summarizes our results. Tyrocidin (the other known ac-
tive component of tyrothricin) is inactivated by serum proteins. Selection of a
TABLE 5
Activities of subtilin in presence of protein, result of growth* in:
DILUTION ON SUBTILIN ALBUMIN 5% SOL. GLOBULIN 1% SOL. BROTH ALONE
1:10,000 — — —
1:80,000 — — —
1:160,000 — — —
1:320,000 — +f +
1:640,000 — + ++
1:1,280,000 ++f ++ ++
Control +++l- +++I. ++++
* Growth of Lactobacillus piantarum at 37°C. for 48 hours.
t Granular growth.
suitable solvent is believed by Henderson to be most important. Another im-
portant attribute of tyrothricin is its heat stability; solutions can be autoclaved.
A final point made by Henderson is that sensitivity to tyrothricin has not been
described either in the experimental laboratory or in the clinic. This would place
tyrothricin above all other antibiotics proposed for topical application.
SUMMARY
Chemical modifications of gramicidin have improved its favorable characteris-
tics. Another surface depressing non-hemolytic antibiotic, subtilin, is more
active in vitro against Lactobacillus plantarum and Mycobacterium tuberculosis in
the presence of "Tween 80." Rupture of the cell membrane and cytolysis of
protozoa have been observed with these antibiotics. Similar mechanisms of cell
injury and death of bacteria have been described for other surface active agents.
These might be classified as "contact" antibiotics.
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Discussion by Dr. Marion B. Sulzberger: In conjunction with what Dr. Ander-
son has just said, it should be emphasized that the antibiotics called tyrothricin
distinguish themselves from penicillin in that they cannot be used systemically;
and that this constitutes a great advantage. Any sensitization which might be
produced by local applications will not deprive the patient of the systemic use of
a drug which might later be necessary to save his life. For the dermatologist,
and for all those schooled and accustomed to topical therapy, tyrothricin has some
other tremendous advantages over penicillin. A first advantage is the stability of
tyrothricin in contrast to the quite unstable penicillin. A second great advantage
is that both experimentally, and from the present clinical experience, it may be
concluded that tyrothricin has a negligible sensitizing potential when compared
with the strongly allergenic penicillin. Moreover, tyrothricin has a larger
spectrum of effectiveness and includes more microorganisms in its ability to
destroy. This offers another advantage, particularly when dealing with so many
mixed dermatologic infections, in which one does not have the means to ascertain
all the microorganisms which may be concerned. As Dr. Anderson brought out,
this material is not water soluble or water miscible; however, there is available
a suitable solution, through the action of the Intraderm vehicles developed by
Doctors MacKee and Herrmann at the New York Skin and Cancer Unit. This
solution (Tyrothricin Intraderm Solution) is relatively non-irritating and is non-
sensitizing, and in our clinical experience to date, it appears to be superior to
any of the other tyrothricin-containing preparations now obtainable.
Discussion by Dr. Merlin T. R. Maynard: I have used tyrothricin clinically
for some time. I have been very much interested in the bases that have been
used for carrying tyrothricin. When this antibiotic was first heard of, I received
from a western laboratory a group of preparations containing pectin and I tried
them out in a few cases with little success. Then, seeking further, I obtained a
polyethylene glycol, of which little has been heard in the literature, and which
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goes under the trade name of "Carbowax 1500". It is very successful as a
carrier for tyrothricin; it does not inhibit its activity in any way. Although of
a consistency like vaseline, it is completely water soluble, and will rinse off the
fingers or hair more easily than most soaps. There is no difficulty with greasiness
on taking it off. Also, it contains no water; it may be that by being relatively
anhydrous it does not cause deterioration which does occur in aqueous solution.
The disadvantage of the pectin base was that it dried on application and formed
a film, thus causing inactivation, but Carbowax makes it useful on any part of
the skin. The only disadvantage is that it absorbs only too readily into the
dressing; however, this may be stiffened by the addition of Carbowax "4000"
which is of the consistency of beeswax. If used in cases of pyodermia or impetigo,
it should be used continuously and I consider it one of my most successful agents
in controlling streptococcus and staphylococcus infections of the skin. It is
colorless and easy to use. The only other form in which I have used tyrothricin
has been the aqueous form; as atomizer and spray it may be sprayed into the
conjunctiva of the eye without causing any appreiable amount of irritation, and
therefore, has been found useful in cases where a streptococcus or staphylococcus
infection of the eye exists. I had only one case that reacted sharply. I do not
know whether it was to the carbowax or to the tyrothricin, as the patient did not
return for patch testing.
Dr. Fred.D. Wiedman: In connection with antibiotics, we should not forget
that when we are dealing with the skin it is not necessary to limit ourselves as
severly as in the case of parenteral administration. Is there any reason, for
example, why living microorganisms, providing it is shown that they have no
capacity for producing pathologic results, should not be called upon? Would it
not be the sensible thing to hope to establish a certain flora upon the skin whereby
pathologic microorganisms alighting thereupon would be destroyed when they
arrived? As a matter of fact, in 1928, before Fleming first brought out peni-
cillin, Dr. Stanley Chambers* essayed that in Philadelphia. He tested various
bacteria obtained from normal toes on the thesis that the donors had been pro-
tected from dermatophytosis, and discovered a certain strain of bacillus which
did, in fact, inhibit Trichophyton gypseum in vitro. It was employed in a series
of cases upon which Dr. Chambers reported at that time, in an ointment that was
put up in collapsible tubes, and called fungistatin. A few years ago, roughly
fifteen years from the time of its original preparation, it was still possible to
recover this strain of bacillus from the ointment, but by that time it had lost its
inhibitory properties against Trichophyton gypseum. Obviously the ability of
the strain had changed during that period and in that abnormal habitat. In
any event, there are possibilitites for experimentation upon the skin which are
not available,—not conceivable, in respect to the employment of antibiotics in
internal disease. We should remember that we may do better than confine our-
selves to the mere extracts of these antibiotic microorganisms; we can employ the
organisms themselves in the living state.
*Chambers, S. 0. and Weidman, F. D.: A Fungistatic Strain of Bacillus Subtilis Iso-
lated From Normal Toes. Arch. D. & S. 18: 528 (Oct.) 1928.
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Closing Discussion by Dr. Hamilton H. Anderson: I appreciate Dr. Sulz-
berger's remarks very much. I think one point of advantage to the dermatologist
in this field is that it is not likely that these agents will be used systemically either
by mouth or parenterally, so that if sensitization does occur, it will be limited to
the area to which the so-called antibiotics have previously been applied. I am
happy to know from Dr. Wiedman of the work done in Philadelphia 15 years
ago. I would have liked to have referred to it. The French have started studies
within the past 2 years, following the suggestions as outlined by Dr. Wiedman, and
they have shown that these bacilli do inactivate toxins of a great number of
organisms—including diphtheria. So that it is conceivable that the so-called
antibiotic action may be developed in that way.
